miR-9 Modulates Osteosarcoma Cell Growth by Targeting the GCIP Tumor Suppressor.

Osteosarcoma is the most common primary bone tumor in humans, especially in childhood. However, the genetic etiology for its pathogenesis remains elusive. It is known that microRNAs (miRNAs) are involved in the development of tumor progression. Here we show that microRNA-9 (miR-9) is a potential oncogene upregulated in osteosarcoma cells. Knockdown of miR-9 in osteosarcoma resulted in suppressed colony formation and cell proliferation. Further study identified GCIP, a Grap2 and cyclin D interacting protein, as a direct target of miR- 9. In addition, GCIP overexpression activated retinoblastoma 1 (Rb) and suppressed E2F transcriptional target expression in osteosarcoma cells. Moreover, GCIP depletion reversed miR-9 knockdown induced colony formation and cell proliferation suppression. In sum, these results highlight the importance of miR-9 as an oncogene in regulating the proliferation of osteosarcoma by directly targeting GCIP and may provide new insights into the pathogenesis of osteosarcoma.

[1]  J. Gu,et al.  Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma , 2010, Oncogene.

[2]  A. Baruzzi,et al.  Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III , 2014, Molecular oncology.

[3]  B. Czerniak,et al.  Bone cancers , 1995, Cancer.

[4]  M. Mison,et al.  Osteosarcoma , 1985, The Lancet.

[5]  Chenguin Li,et al.  Research progress on the livin gene and osteosarcomas. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[6]  A. Mantovani,et al.  Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals , 2009, Proceedings of the National Academy of Sciences.

[7]  Mingyao Liu,et al.  GCIP, a Novel Human Grap2 and Cyclin D Interacting Protein, Regulates E2F-mediated Transcriptional Activity* , 2000, The Journal of Biological Chemistry.

[8]  Lihua Li,et al.  MiR-133b Is Down-Regulated in Human Osteosarcoma and Inhibits Osteosarcoma Cells Proliferation, Migration and Invasion, and Promotes Apoptosis , 2013, PloS one.

[9]  Soundararajan Vijayarathna,et al.  MicroRNAs: biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[10]  Jiexiong Feng,et al.  Review of the molecular pathogenesis of osteosarcoma. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[11]  Frank Speleman,et al.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis , 2010, Nature Cell Biology.

[12]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[13]  Wei Wu MicroRNA and Cancer , 2011, Methods in Molecular Biology.

[14]  V. Kim,et al.  Regulation of microRNA biogenesis , 2014, Nature Reviews Molecular Cell Biology.

[15]  F. Wang,et al.  Expression of GCIP in transgenic mice decreases susceptibility to chemical hepatocarcinogenesis , 2006, Oncogene.

[16]  Q. Kan,et al.  Induction of microRNA-9 mediates cytotoxicity of curcumin against SKOV3 ovarian cancer cells. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[17]  Hua Su,et al.  MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. , 2010, Cell stem cell.

[18]  C-C Chen,et al.  Ribosomal phosphoprotein P0 interacts with GCIP and overexpression of P0 is associated with cellular proliferation in breast and liver carcinoma cells , 2008, Oncogene.

[19]  Cao Yang,et al.  miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression. , 2014, Biochemical and biophysical research communications.

[20]  Carl R Walkley,et al.  Cells of origin in osteosarcoma: mesenchymal stem cells or osteoblast committed cells? , 2014, Bone.

[21]  Matthew A. Titmus,et al.  Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells , 2010, Molecular Cancer.

[22]  Zhaoshi Jiang,et al.  Tumour‐secreted miR‐9 promotes endothelial cell migration and angiogenesis by activating the JAK‐STAT pathway , 2012, The EMBO journal.

[23]  W. Kang,et al.  A novel senescence-evasion mechanism involving Grap2 and Cyclin D interacting protein inactivation by Ras associated with diabetes in cancer cells under doxorubicin treatment. , 2010, Cancer research.

[24]  M. Chang,et al.  GCIP functions as a tumor suppressor in non-small cell lung cancer by suppressing Id1-mediated tumor promotion , 2014, Oncotarget.

[25]  W‐C. Chen,et al.  Immunohistochemical expression of GCIP in breast carcinoma: relationship with tumour grade, disease‐free survival, mucinous differentiation and response to chemotherapy , 2008, Histopathology.

[26]  D. Jiang,et al.  miR-155 inhibitor reduces the proliferation and migration in osteosarcoma MG-63 cells , 2014, Experimental and therapeutic medicine.

[27]  F. Gao,et al.  miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells. , 2013, Biochemical and biophysical research communications.

[28]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.